Skip to main content
. 2017 Jan 21;6(4):249–257. doi: 10.1002/psp4.12160

Figure 2.

Figure 2

Effect of body weight, antidrug antibodies (ADAs), and race on clearance (CL), volume of distribution of the central compartment (Vc), and volume of distribution of the peripheral compartment (Vp) of benralizumab; each open circle represents one individual study participant.